BioAge Labs, Inc.
BIOA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $1 | $0 |
| % Growth | -14.8% | 66.2% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2 | $2 | $1 | $0 |
| % Margin | 100% | 100% | 100% | – |
| R&D Expenses | $19 | $20 | $11 | $19 |
| G&A Expenses | $7 | $7 | $7 | $6 |
| SG&A Expenses | $7 | $7 | $7 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $25 | $27 | $18 | $25 |
| Operating Income | -$23 | -$25 | -$16 | -$25 |
| % Margin | -1,126.6% | -1,027% | -1,133.4% | – |
| Other Income/Exp. Net | $3 | $3 | $4 | $4 |
| Pre-Tax Income | -$20 | -$22 | -$13 | -$21 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$20 | -$22 | -$13 | -$21 |
| % Margin | -982% | -894% | -891% | – |
| EPS | -0.56 | -0.6 | -0.36 | -1.97 |
| % Growth | 6.7% | -66.7% | 81.7% | – |
| EPS Diluted | -0.56 | -0.6 | -0.36 | -1.97 |
| Weighted Avg Shares Out | 36 | 36 | 36 | 36 |
| Weighted Avg Shares Out Dil | 36 | 36 | 36 | 36 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $3 | $4 | $4 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$20 | -$21 | -$13 | -$21 |
| % Margin | -972.4% | -883.3% | -870.8% | – |